Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
FILSPARI35.62M56.63%
Tiopronin products25.38M40.35%
License and collaboration revenue1.9M3.02%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States145.24M100.00%